Private Placement

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Major deals with Cadillac and Ferrari mark a pivotal year for Research Frontiers, but can its smart glass tech overcome growing financial losses?

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

With a fresh $72M in financing, Canadian innovator Activate is betting big on its unique blend of physical gaming to build a global entertainment empire.

The Bloomberg 500 adds 11 tech-heavy firms like Nebius Group and ASTS, signaling a major shift in market leadership driven by AI and digital infrastructure.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

Yarbo's all-season yard robot hit $1M on Kickstarter in record time, signaling a major shift in how we manage our lawns, gardens, and driveways.

After a four-year regulatory journey, AquaBoreal's massive salmon farm gets key approval, promising to boost Quebec's food security and revitalize a region.

Strong investor demand leads to upsized funding, set to accelerate drilling at the high-grade Ballywire project, heralded as Ireland's next big mineral find.

With strong revenue growth and critical FDA decisions on the horizon, MannKind's leadership prepares to outline its vision for investors in Miami.

In a booming aesthetics market, one company is enlisting elite surgeons to architect the future of recovery, aiming to close a critical gap in patient care.

In Galway, a high-trust summit convenes global security leaders to address AI's role in a world of hybrid threats and geopolitical instability.

Amid a volatile market, Ligand presents its sustainable growth blueprint, powered by royalties and partnerships, to top investors this March.

The Good Game app launches in Kansas, promising to unite the fragmented youth sports market with a single platform for booking, safety, and gig work.

With a new C-suite hire, Utah's Silicon Ridge project is poised to become a cornerstone of America's strategic mineral independence from a single deposit.

A major investment from All Seas Capital will fuel Sereni's rapid consolidation of Europe's fragmented funeral industry, signaling a new era of modernization.